Impaired Th1 responses in mice deficient in Epstein-Barr virus-induced gene 3 and challenged with physiological doses of Leishmania major

European Journal of Immunology

Volumn 35, Issue 4, 2005, Pages 1106-1112

  Zahn, Sabine ^a   Wirtz, Stefan ^a   Birkenbach, Mark ^b   Blumberg, Richard S ^c   Neurath, Markus F ^a   von Stebut, Esther ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF VIRGINIA   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Dendritic cell; IL 12; IL 27; Leishmania major; Th1 Th2

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 27; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EPSTEIN BARR VIRUS; GENE INDUCTION; IMMUNE DEFICIENCY; IMMUNOSTIMULATION; LEISHMANIA MAJOR; LEISHMANIASIS; LYMPH NODE; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PARASITE IMMUNITY; PARASITE TRANSMISSION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROVOCATION TEST; SKIN DEFECT; TH1 CELL; WILD TYPE;

ANIMALS; DENDRITIC CELLS; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; RECEPTORS, CYTOKINE; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS; TH1 CELLS;

EID: 17444387109     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425926     Document Type: Article

References (31)

1. Reiner, S.L. and Locksley, R.M., The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 1995. 13: 151-177.
2. Sacks, D. L. and Noben-Trauth, N., The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev Immunol. 2002. 2: 845-858.
3. Flohe, S. B., Bauer, C., Flohe, S. and Moll, H., Antigen-pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major. Eur. J. Immunol. 1998. 28: 3800-3811.
4. von Stebut, E., Belkaid, Y., Jakob, T., Sacks, D. L. and Utley, M. C., Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J. Exp. Med. 1998. 188: 1547-1552.
5. von Stebut, E., Belkaid, Y., Nguyen, B. V., Cushing, M., Sacks, D. L. and Udey, M. C., Leishmania major-infected murine langerhans cell like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis. Eur. J. Immunol. 2000. 30: 3498-3506.
6. / setting. Immunity 2002. 16: 429-439.
7. von Stebut, E., Ehrchen, J. M., Belkaid, Y., Lopez Kostka, S., Molle, K., Knop, J., Sunderkotter, C. and Udey, M. C., Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice. J. Exp. Med. 2003. 198: 191-199.
8. + T cell polarization in mice is modulated by strain-specific major histocompatibility complex-independent differences within dendritic cells. J. Exp. Med. 2003. 198: 201-209.
9. Yoshida, H., Hamano, S., Senaldi, G., Covey, T., Faggioni, R., Mu, S., Xia, M., Wakeham, A. C., Nishina, H., Potter, J., Saris, C. J. and Mak, T. W., WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 2001. 15: 569-578.
10. Pflanz, S., Hibbert, L., Mattson, J., Rosales, R., Vaisberg, E., Bazan, J. F., Phillips, J. H., McClanahan, T. K., de Waal Malefyt, R. and Kastelein, R. A., WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 2004. 172: 2225-2231.
11. Artis, D., Johnson, L. M., Joyce, K., Saris, C., Villarino, A., Hunter, C. A. and Scott, P., Cutting edge: early IL-4 production governs the requirement for IL-27-WSX-1 signalling in the development of protective Th1 cytokine responses following Leishmania major infection. J. Immunol. 2004. 172: 4672-4675.
12. Chen, Q., Ghilardi, N., Wang, H., Baker, T., Xie, M. H., Gurney, A., Grewal, I. S. and de Sauvage, F. J., Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature 2000. 407: 916-920.
13. Villarino, A., Hibbert, L., Lieberman, L., Wilson, E., Mak, T., Yoshida, H., Kastelein, R. A., Saris, C. and Hunter, C. A., The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 2003. 19: 645-655.
14. Hamano, S., Himeno, K., Miyazaki, Y., Ishii, K., Yamanaka, A., Takeda, A., Zhang, M., Hisaeda, H., Mak, T. W., Yoshimura, A. and Yoshida, H., WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. Immunity 2003. 19: 657-667.
15. Bancroft, A. J., Humphreys, N. E., Worthington, J. J., Yoshida, H. and Grencis, R. K., WSX-1: a key role in induction of chronic intestinal nematode infection. J. Immunol. 2004. 172: 7635-7641.
16. + T cells. Immunity. 2002. 16: 779-790.
17. Yamanaka, A., Hamano, S., Miyazaki, Y., Ishii, K., Yamanaka, A., Takeda, A., Zhang, M., Hisaeda, H., Mak, T. W., Yoshimura, A. and Yoshida, H., Hyperproduction of proinflammatory cytokines by WSX-1-deficient NKT cells in concanavalin A-induced hepatitis. J. Immunol. 2004. 172: 3590-3596.
18. Nieuwenhuis, E. E., Neurath, M. F., Corazza, N., Iijima, H., Trgovcich, J., Wirtz, S., Glickman, J., Bailey, D., Yoshida, M., Galle, P. R. et al., Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice. Proc. Natl. Acad. Sci. USA 2002. 99: 16951-16956.
19. Villarino, A. V., Huang, E. and Hunter, C. A., Understanding the pro- and anti-inflammatory properties of IL-27. J. Immunol. 2004. 173: 715-720.
20. Belkaid, Y., Mendez, S., Lira, R., Kadambi, N., Milon, G. and Sacks, D. L., A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity. J. Immunol. 2000. 165: 969-977.
21. Larousserie, F., Pflanz, S., Coulomb-L'Hermine, A., Brousse, N., Kastelein, R. and Devergne, O., Expression of IL-27 in human Th1-associated granulomatous diseases. J. Pathol. 2004. 202: 164-71.
22. + T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major. J. Immunol. 2002. 168: 3992-4000.
23. + regulatory T cells control Leishmania major persistence and immunity. Nature 2002. 420: 502-507.
24. Artis, D., Villarino, A., Silverman, M., He, W., Thornton, E. M., Mu, S., Summer, S., Covey, T. M., Huang, E., Yoshida, H. et al., The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity. J. Immunol. 2004. 173: 5626-5634.
25. Amprey, J. L., Im, J. S., Turco, S. J., Murray, H. W., Illarionov, P. A., Besra, G. S., Porcelli, S. A. and Spath, G. F., A subset of liver NK T cells is activated during Leishmania donovanii infection by CD1d-bound lipophosphoglycan. J. Exp. Med. 2004. 200: 895-904.
26. Park, A. Y., Hondowicz, B. D. and Scott P., IL-12 is required to maintain a Th1 response during Leishmania major infection. J. Immunol. 2000. 165: 896-902.
27. Ahuja, S. S., Reddick, R. L., Sato, N., Montalbo, E., Kostecki, V., Zhao, W., Dolan, M. J., Melby, P. C. and Ahuja, S. K., Dendritic cell (DC)-based anti-infective strategies: DCs engineered to secrete IL-12 are a potent vaccine in a murine model of an intracellular infection. J. Immunol. 1999. 163: 3890-3897.
28. Hashimoto, S. I., Suzuki, T., Nagai, S., Yamashita, T., Toyoda, N. and Matsushima, K., Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression. Stood 2000. 96: 2206-2214.
29. van Seventer, J. M., Nagai, T. and van Seventer, G. A., Interferon-beta differentially regulates expression of the IL-12 family members p35, p40, p19 and EBI3 in activated human dendritic cells. J. Neuroimmunol. 2002. 133: 60-71.
30. Brombacher, F., Kastelein, R. A. and Alber, G., Novel IL-12 family members shed light on the orchestration of Th1 responses. Trends Immunol. 2003. 24: 207-212.
31. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S. and Steinman, R. M., Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1992. 176: 1693-1702.